Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc daily Stock Chart
GlaxoSmithKline plc
Index- P/E7.77 EPS (ttm)5.06 Insider Own- Shs Outstand2.43B Perf Week-3.81%
Market Cap95.49B Forward P/E14.90 EPS next Y2.64 Insider Trans- Shs Float2.43B Perf Month-0.20%
Income12.21B PEG12.96 EPS next Q- Inst Own9.20% Short Float0.19% Perf Quarter-4.82%
Sales34.69B P/S2.75 EPS this Y204.80% Inst Trans0.34% Short Ratio1.28 Perf Half Y-10.42%
Book/sh3.08 P/B12.77 EPS next Y4.85% ROA15.40% Target Price47.33 Perf Year-10.41%
Cash/sh3.55 P/C11.09 EPS next 5Y0.60% ROE135.80% 52W Range36.72 - 47.14 Perf YTD-2.50%
Dividend2.20 P/FCF- EPS past 5Y40.20% ROI41.40% 52W High-16.55% Beta0.83
Dividend %5.59% Quick Ratio0.90 Sales past 5Y-3.40% Gross Margin66.40% 52W Low7.14% ATR0.99
Employees98702 Current Ratio1.20 Sales Q/Q1.60% Oper. Margin47.00% RSI (14)44.02 Volatility1.96% 2.08%
OptionableYes Debt/Eq3.25 EPS Q/Q-133.30% Profit Margin35.40% Rel Volume1.95 Prev Close39.47
ShortableYes LT Debt/Eq3.00 EarningsFeb 03 Payout45.50% Avg Volume3.53M Price39.34
Recom2.00 SMA20-2.01% SMA50-2.06% SMA200-4.34% Volume6,797,300 Change-0.33%
Dec-09-15Upgrade BofA/Merrill Neutral → Buy
Dec-07-15Reiterated Argus Buy $52 → $48
Oct-20-15Upgrade Credit Suisse Underperform → Neutral
Sep-15-15Upgrade Exane BNP Paribas Underperform → Neutral
Sep-08-15Upgrade BofA/Merrill Underperform → Neutral
Jun-26-15Upgrade Liberum Sell → Hold
Jun-04-15Downgrade Morgan Stanley Overweight → Equal-Weight
May-20-15Resumed Citigroup Neutral
Apr-15-15Initiated Societe Generale Sell
Feb-19-15Reiterated Argus Buy $55 → $52
Aug-08-14Reiterated Argus Buy $65 → $55
Apr-23-14Upgrade Argus Hold → Buy
May-28-13Upgrade Deutsche Bank Hold → Buy
Jan-11-11Upgrade Jefferies Hold → Buy
Jun-02-10Upgrade Jefferies Hold → Buy
Feb-16-10Upgrade JP Morgan Underweight → Neutral $26
Jan-13-10Downgrade Credit Suisse Outperform → Underperform
Nov-24-09Initiated Leerink Swann Mkt Perform
Nov-16-09Initiated Deutsche Securities Hold
Nov-12-09Initiated Barclays Capital Equal Weight
Feb-09-16 02:49PM  GlaxoSmithKline Plc Value Analysis (NYSE:GSK) : February 9, 2016
10:58AM  Pfizer Reported 7% Top Line Growth in 4Q15
08:36AM  Alkermes CEO Richard Pops Isn't Giving Up On Breakthrough Depression Drugs at Forbes
04:40AM  Has This Bear Market Made Lloyds Banking Group Plc, GlaxoSmithKline Plc, And British American Tobacco Plc Bargain Buys?
Feb-08-16 10:06AM  Can NewLink Genetics Win the Zika Vaccine Race? at Motley Fool
09:58AM  GlaxoSmithKline Plc Earnings Analysis: 2015 By the Numbers
08:45AM  Top of The List: Largest Biotech/Pharma Companies and Largest CROs at
07:10AM  Biogen joins international effort to share preclinical data at
04:00AM  Why I'd Buy GlaxoSmithKline plc Over Smith & Nephew plc And Shire PLC
Feb-06-16 09:18AM  Why Ionis Pharmaceuticals Inc Plunged 36% in January at Motley Fool
Feb-05-16 11:53AM  Neil Woodford Sells GlaxoSmithKline plc -- But Don't Panic!
09:14AM  Beginners' Portfolio: GlaxoSmithKline plc Gains Ground, while BP plc And Barclays PLC Are Faltering
Feb-04-16 04:49PM  4 Can't-Miss Numbers From GlaxoSmithKline's Fourth-Quarter Results at Motley Fool
04:26PM  Moody's Affirms Six Classes of COMM 2015-LC19 at Moody's
03:59PM  Is Inovio Pharmaceuticals' Zika Surge Premature? at Motley Fool
09:40AM  Glaxo Tops Q4 Earnings, Revenues Rise Y/Y, 2016 View Intact
07:01AM  3 Value Stocks Near 52-Week Lows Worth Buying at Motley Fool
04:20AM  Why GlaxoSmithKline plc, Aviva plc & Trifast plc Are Beaming Bargains!
Feb-03-16 08:31PM  PRESS DIGEST- British Business - Feb 4 Reuters
12:42PM  [$$] GlaxoSmithKline: Playing the Waiting Game at The Wall Street Journal
12:18PM  Notable option activity in equity names
10:46AM  Limited gains seen for GlaxoSmithKline
10:34AM  [$$] Investors' Fears Eased as Glaxo Posts Solid Results at The Wall Street Journal
09:33AM  GSK refuses to be bounced into early consumer unit spin-off
08:47AM  Do Today's Results Make GlaxoSmithKline plc A Contrarian Buy?
08:42AM  Glaxo (GSK) Beats on Q4 Earnings, Revenues Rise Y/Y
08:17AM  GlaxoSmithKline posts loss as it integrates new businesses
07:59AM  Sen. Ted Cruz Wants To Change The Way The FDA Approves Drugs at Forbes
07:14AM  New drugs help GSK offset drag of flagging Advair sales
07:10AM  Glaxo Fourth-Quarter Profit Falls, Missing Analyst Estimates at Bloomberg
Feb-02-16 07:07PM  Why Axovant Sciences Shares Are Crashing at Motley Fool
01:09PM  Axovant Falls Back to Earth at Bloomberg
12:07PM  Gilead Sciences: It's Almost Earnings Time at
11:05AM  GlaxoSmithKline & Adaptimmune expand immunotherapy partnership at
08:37AM  Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration GlobeNewswire
08:16AM  Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration GlobeNewswire
07:44AM  Forget Merck & Co. Inc.: Here Are 2 Better Dividend Stocks at Motley Fool
05:12AM  GSK and J&J back $1 billion biotech spin-off from Index Ventures
01:00AM  GSK and J&J back $1 bln biotech spin-off from Index Ventures
Feb-01-16 04:30PM  Can GlaxoSmithKline (GSK) Q4 Earnings Surprise Estimates?
04:07PM  Novartiss 2015 Revenues Rise 5% at Constant Currencies
04:07PM  Novartis Reports Operational Growth in 4Q15
01:07PM  Can Consumer Healthcare Drive Sanofis Revenue?
12:08PM  [$$] Investor calls for big pharma to slim down grow louder at Financial Times
08:00AM  Technical Pointers on Drug Manufacturers - Major Stocks -- Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, and AstraZeneca Accesswire
07:38AM  Are Diageo plc, British American Tobacco plc & GlaxoSmithKline plc Safe Ports In Today's Storms?
Jan-31-16 02:18PM  3 Feverishly Bad Flu Myths That Should Be Put to Rest at Motley Fool
10:05AM  [$$] Week Ahead Corporate Diary: February 1 - February 5 at Financial Times
Jan-29-16 04:39PM  Biotech Stocks Soar In Race To Create Zika Vaccine at Forbes
04:05PM  Take a photo tour of GSK's new Navy Yard offices at
02:02PM  The 3 Most Important Numbers When GlaxoSmithKline Reports Its Fourth-Quarter Results at Motley Fool
01:38PM  EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4
05:16AM  GlaxoSmithKline plc: Next Stop 1,600P
03:04AM  Will GSKs Consumer Healthcare Sustain Growth during 4Q15?
Jan-28-16 03:58PM  CDXS and LOGI are Aggressive Growth Stocks
03:50PM  A Small-Cap Biotech With Big Ideas for Acute Infections and Cancers: Cellceutix's Leo Ehrlich and Dr. Daniel Jorgensen Marketwired
10:25AM  Novartis (NVS) Lags Q4 Earnings & Revenues, Alcon Down
08:05AM  Is Another Big Transformation on the Way for GlaxoSmithKline? at Motley Fool
03:20AM  GlaxoSmithKline plc And Smith & Nephew plc: Healthy Stock Stars For Your Portfolio!
12:44AM  [$$] Cancer Centers Urge Increase in HPV Vaccinations at The Wall Street Journal
Jan-27-16 03:10PM  U.S. would play muted role if GSK looks for new CEO at
03:20AM  Will GlaxoSmithKline plc Slide To £10 Or Soar To £20?
Jan-26-16 12:40PM  Drug Sales Are Driving Johnson & Johnsons Growth at Fortune
07:45AM  Forget Pfizer Inc.: Here Are 2 Better Dividend Stocks at Motley Fool
07:20AM  GSKs 4Q15 Earnings: What to Expect from the Vaccines Business
07:20AM  GSKs 4Q15 Earnings: Will Pharmaceuticals Grow?
03:46AM  Will Dividends Continue At Super Yielders Vodafone Group Plc And GlaxoSmithKline Plc?
Jan-25-16 04:22PM  How the VEURX Allocated Its 2015 Portfolio
12:53PM  Why OncoMed Pharmaceuticals' Stock Crashed Today at Motley Fool
12:14PM  Zika virus set to spread across Americas, spurring vaccine hunt
10:55AM  GSK evaluating possibility of using vaccine technology for Zika Reuters
08:20AM  OncoMed stock plunges after negative findings by study monitoring board at MarketWatch
Jan-22-16 03:40AM  Astrazeneca Plc And GlaxoSmithKline Plc: Double Or Quits?
Jan-21-16 10:18AM  Drug firms ask governments to do more in fight against superbugs Reuters
06:05AM  Pharma firms worlwide unite to battle superbugs at
03:26AM  GSK?s Witty Sees EU Member Benefits
03:26AM  GSKs Witty Sees EU Member Benefits at Bloomberg
03:23AM  GSK CEO on Drug Pricing, Corporate Inversions
02:16AM  Glaxo Chief Says Consumer Health Unit Can Exist on Its Own at Bloomberg
01:06AM  [$$] Five Charged With Conspiring to Steal Trade Secrets From GlaxoSmithKline at The Wall Street Journal
Jan-20-16 09:28PM  Drug industry to fight superbugs together with governments
07:13PM  5 charged in alleged scheme to steal drug secrets
07:01PM  Big Pharma Pushes for New Antibiotic Funds to Fight Superbugs at Bloomberg
06:44PM  [$$] Five Charged of Conspiring to Steal Trade Secrets From Glaxo at The Wall Street Journal
04:10PM  Five charged in alleged scheme to steal GSK trade secrets at
01:22PM  GSK said to be in talks with Qualcomm to form JV - Bloomberg Reuters
08:21AM  Solving Pharma's Shkreli Problem at Forbes
Jan-19-16 03:40AM  GlaxoSmithKline plc, Reckitt Benckiser Group Plc & British American Tobacco plc: Secure Stocks For Volatile Times?
Jan-18-16 08:37AM  Beginners' Porfolio: Falls From GlaxoSmithKline plc, Persimmon plc & BP plc Push Returns Down To 25%
07:18AM  Novartiss 4Q15 Revenue Estimates: Expect a Fall!
07:18AM  Novartis Will Report Its 4Q15 Earnings on January 27
Jan-17-16 12:04PM  [$$] Antitrust watchdog gives notice of 'substantial fines' at Financial Times
Jan-15-16 01:29PM  Analysts Project Dip in Teva Pharmaceutical Revenues in 4Q15
08:00AM  Betting on Fallen Angels Could Be Heavenly
Jan-14-16 01:27PM  What Are Analysts Saying about TEVA?
10:10AM  5 Reasons Why GlaxoSmithKline Shareholders Should Be Excited About the Future at Motley Fool
Jan-13-16 12:02PM  3 Reasons Behind Amarin's Strong 2015 at Motley Fool
10:45AM  GlaxoSmithKlines 4Q15 Revenues Expected to Rise
10:43AM  What to Expect from GlaxoSmithKlines 4Q15 Earnings
08:19AM  Mylan N.V. Fires a Shot at GlaxoSmithKline at Motley Fool
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company's wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company's nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc has a collaboration agreements with Universit de Sherbrooke and Pfizer Inc.; development agreement, and R and D collaboration with Propeller Health; and collaboration and license agreement with Idera pharmaceuticals, Inc. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerMay 11Buy14.00365,1065,111,484365,106May 13 12:36 PM
GLAXOSMITHKLINE PLC10% OwnerMar 02Buy18.0692,6741,673,69231,673,853Mar 02 03:45 PM